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Iron dextran in the treatment of iron-deficiency
anaemia of pregnancy
Haematological response and incidence of side-effects
M. L. STEIN, K. D. GUNSTON, R. M. MAY
Summary
Sixty pregnant patients with a haemoglobin (Hb) < 8 g/dl
arid proven iron-deficiency anaemia were randomly allocated
to two treatment groups. Group A received the usual recom.
mended dose of iron dextran (Imferon; Fisons) and group 8
received two-thirds of the recommended dose. A further 30
patients received oral iron (group C). There was no difference
in Hb value between the three groups 4 weeks after treatment
or 3 months after delivery. At 6 months after delivery, a higher
mean Hb value was found in the patients in group A than
those in groups 8 and C. Significantly higher serum ferritin
levels were found in group A and this difference was still
present 6 months postnatally. There was no significant dif-
ference in the incidence of delayed reactions between the
two groups who received iron dextran.
S Atr Med J 1991; 79: 195-196.
A significant number of antenatal patients with a low haemo-
globin (Hb) value book late in pregnancy. Most of them have
iron deficiency anaemia. l Total dose infusion (TDI) with iron
dextran is an accepted form of treatment in pregnant iron-
deficient women who cannot be managed on oral iron therapy.2
In order to reduce the need for blood transfusion before
delivery, it is necessary to use a method of treatment in iron
deficiency anaemia which will raise the Hb level rapidly.
Many patients will not take oral iron reliably because of poor
motivation or the presence of side-effects.
Of the various laboratory measurements to assess iron status,
the serum ferritin value is the most sensitive and specific
indicator of iron deficiency, a level below 12 ).Lg/l being
absolutely diagnostic.3 In normal pregnancy, however, studies
have shown that the serum ferritin level decreases, reaching
levels of 15 ).Lg/l or less in the 3rd trimester. When admini-
stering iron therapy, the serum ferritin value remains a valid
measurement of body iron stores and it is thus useful not only
in identifying iron deficiency but in monitoring its repairY
Imferon (Fisons), an iron dextran complex, has been available
for almost 30 years as a parenteral treatment for iron-deficiency
anaemia. Its administration is associated in some patients with
a delayed reaction characterised by arthralgia, myalgia, malaise
and pyrexia.5,6 It has been suggested that the incidence of
delayed reactions is dose-related.7
A study was undertaken to ascenain whether the haema-
tological response and the incidence of delayed reactions would
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be significantly reduced using a lower dose of iron dextran and
to assess whether parenteral iron dextran would raise the
haemoglobin value more rapidly than the use of oral iron.
Patients and methods
Sixty patients with an Hb value of < 8 g/dl and proven iron-
deficiency anaemia, who were either non-eompliant or intole-
rant of oral iron, were randomly allocated to two treatment
groups. Group A received the full calculated dosage of iron
dextran including the additional 10 ml for pregnancy, while
group B received two-thirds of the recommended dose. The
[mal number of patients who received the full dose was 31,
while 29 patients received the two-thirds dose. Group C con-
sisted of 30 patients who received, and were able to take, oral
Iron.
Patients with a known hypersensitivity to iron dextran, a
history of asthma, rheumatoid arthritis or confIrmed urirJary
tract infection were excluded.
A research sister was appointed to administer and to observe
the patients throughout the infusion. One week after TDI the
research sister contacted the patients to enquire about the
occurrence of a delayed reaction.
The Rb estimations were measured before infusion or stan
of oral iron, 4 weeks after treatment, and 3 and 6 months after
delivery.
Serum ferritin estimations were carried out according to the
method of Dempster er a/.,8 before initiating the treatment, 8
weeks after treatment and 6 months after delivery. As the data
were skewed, an analysis of variance was performed on log
transformed data, with posthoc r-tests on those groups showing
significant differences.
The delayed reactions to the TDI were graded as follows:
grade 0 - no reaction; grade 1 - arthralgia and myalgia; and
grade 2 - pain, malaise and pyrexia requiring admission to
hospital.
Results
The Hb response is shown in Table I.
There was no statistically significant difference between the
three treatment groups before treatment, 4 weeks after treat-
ment and 3 months after delivery. At 6 months after delivery
the patients in group A had a statistically significant higher
mean Rb value than the patients in groups B and C. The
results of the measurement of serum ferritin levels show that
at 8 weeks after treatment and 6 months after delivery the
mean serum ferritin values were significantly higher in group
A than in either of the other two groups.
None of the 60 patients experienced an acute anaphylactoid
reaction to the iron dextran.
The incidence of delayed reactions is also shown in Table I.
Using the ;X2 test of independence of variables, it was found
that the incidence of side-effects was not dependent on dose.
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TABLE I. HAEMATOLOGICAL RESPONSE AND INCIDENCE OF SIDE-EFFECTS
Haemoglobin Ferritin Side-effects
Group A Group B Group C Group A Group B Group C Grades Group A Group B
Before treatment 7,35 7,44 7,25 6,60 9,38 7,33 0 10 10
1 moo after treatment 9,95 10,06 9,78 1 15 17
2 moo after treatment 171,24(S)t 101,32 54,73 2 6 2
3 moo after delivery 12,87 12,27 13,02
6 moo after delivery 13,49(S)" 12,40 12,82 137,59(S)tt 51,76(S)§ 27,47
"t-test h v. B (P < 0,005) tt-test A v. B (P = 0,0006)
"t-test A v. C (P < 0,01) tt I-test A v. B (P= 0,0003)
§ t-test B v. C (P = 0,014)
Discussion
Intravenous administration of iron dextran is a safe and reliable
method of correcting iron-deficiency anaemia in a patient who
is precluded from oral iron therapy.9 In this study the dose of
iron dextran was lowered in an attempt to reduce the occur-
rence of reactions, but still achieve a satisfactory improvement
in the Hb and serum ferritin values.
However, in view of the fact that the incidence of delayed
reactions was not significantly reduced by using the two-thirds
dose, and that the ferritin levels were higher with the full dose,
it is advisable that the full recommended dose of iron dextran
be used. Parenteral iron dextran did not raise the Hb value
more rapidly than oral iron in compliant patients.
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